Risperidone-associated agranulocytosis.
Finkel
B
B
Lerner
A G
AG
Oyffe
I
I
Sigal
M
M
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000097:blood / Q000188:drug therapy
D014150:Antipsychotic Agents; D018967:Risperidone